R43AG094486↗
Advanced Brain Monitoring, Inc. received this grant or assistance award from National Institutes of Health: $690.9K obligated so far for aging research. Its latest action was on 2026-06-25.
Key facts · data as of Oct 26, 2026
- Recipient
- Advanced Brain Monitoring, Inc.
- Awarding agency
- National Institutes of Health (Department of Health and Human Services)
- Obligated to date
- $690.9K
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 26, 2026.
Cite this page: SpendQuery, Award R43AG094486, data as of Oct 26, 2026, https://spendquery.com/award?id=ASST_NON_R43AG094486_075
Advanced Brain Monitoring, Inc.: all federal awards · Department of Health and Human Services: spending
CHARACTERIZING NEUROCOGNITIVE DEFICITS IN POST-ACUTE SEQUELAE OF COVID-19 - ABSTRACT POST-ACUTE SEQUELAE OF COVID-19 (PASC), OR LONG COVID, IS AN EMERGING GLOBAL HEALTH CRISIS WITH AN URGENT NEED FOR OBJECTIVE ASSESSMENT TOOLS TO QUANTIFY NEUROCOGNITIVE DEFICITS. THIS PROPOSAL AIMS TO VALIDATE AND LEVERAGE A NOVEL MOBILE ELECTROENCEPHALOGRAPHY (EEG) PLATFORM TO PROVIDE ACCESSIBLE, COST-EFFECTIVE COGNITIVE ASSESSMENTS FOR INDIVIDUALS SUFFERING FROM NEUROLOGICAL MANIFESTATIONS OF PASC (NPASC). OUR PRELIMINARY DATA SUGGESTS THAT EEG/EVENT-RELATED POTENTIAL (ERP) BIOSIGNATURES, INCLUDING DELAYED NEURAL RESPONSES DURING AUDITORY AND MEMORY TASKS, ARE SENSITIVE TO COGNITIVE IMPAIRMENTS IN NPASC. HOWEVER, THE TRAJECTORY AND SPECIFICITY OF THESE DEFICITS REMAIN UNCLEAR. THIS STUDY WILL VALIDATE THESE PRELIMINARY FINDINGS IN A LARGER COHORT (N=52) AND LONGITUDINALLY MONITOR CHANGES OVER ONE YEAR TO MAP RECOVERY OR DETECT EARLY SIGNS OF PERSISTENT COGNITIVE DECLINE. THE INNOVATIVE APPROACH INTEGRATES RESTING-STATE EEG WITH MULTIPLE TASK-BASED ERP PROTOCOLS, ENABLING COMPREHENSIVE PROFILING OF NEURAL DYSFUNCTION ASSOCIATED WITH NPASC. LEVERAGING ADVANCED BRAIN MONITORING'S FDA-CLEARED MOBILE EEG PLATFORM AND VALIDATED ANALYSIS PIPELINES WILL PROVIDE A SCALABLE SOLUTION FOR WIDESPREAD CLINICAL USE AND REMOTE ASSESSMENTS. IF SUCCESSFUL, THIS STUDY WILL DELIVER A QUANTITATIVE EEG/ERP BIOMARKER PROFILE SPECIFIC TO NEURO-PASC, ENABLING OBJECTIVE EVALUATION OF COGNITIVE DEFICITS. LONGITUDINAL MONITORING WILL ELUCIDATE THE NATURAL TRAJECTORY, IDENTIFY POTENTIAL RISK FACTORS FOR PERSISTENT IMPAIRMENT, AND PROVIDE OUTCOME MEASURES FOR FUTURE THERAPEUTIC INTERVENTIONS. THIS INNOVATIVE DIAGNOSTIC TOOL WILL EMPOWER PATIENTS AND CLINICIANS BY PROVIDING OBJECTIVE EVIDENCE OF NPASC SEVERITY AND TREATMENT EFFICACY.
What it is
- Program
- Aging Research (Assistance Listing 93.866)
- Where the work is
- San Diego, CA · district CA-49
- Topics
- covid
The research project
Characterizing neurocognitive deficits in post-acute sequelae of COVID-19 · National Institute on Aging (NIA) · led by Amir Hossein Meghdadi and 1 more, ADVANCED BRAIN MONITORING, INC.
“Post-acute sequelae of COVID-19 (PASC), or Long COVID, is an emerging global health crisis with an urgent need for objective assessment tools to quantify neurocognitive deficits.” Full abstract on RePORTER ↗
NIH funding by fiscal year: FY2025 $325.7K · FY2026 $365.2K ($690.9K in all) · project period 2025-09-16 to 2027-05-31.
Source: NIH RePORTER, project R43AG094486. RePORTER counts NIH's awards by year; USAspending's obligations above count each action.
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subrecipients: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
2 actions since 2025-09-16. Each is a modification or amendment with the money it added or took back.
| Date | Amendment | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-06-25 | 000 | Continuation | $365.2K | CHARACTERIZING NEUROCOGNITIVE DEFICITS IN POST-ACUTE SEQUELAE OF COVID-19 - ABSTRACT POST-ACUTE SEQUELAE OF COVID-19 (PASC), OR LONG COVID, IS AN EMERGING GLOBAL HEALTH CRISIS WITH AN URGENT NEED FOR OBJECTIVE ASSESSMENT TOOLS TO QUANTIFY NEUROCOGNITIVE… |
| 2025-09-16 | 000 | New award | $325.7K | CHARACTERIZING NEUROCOGNITIVE DEFICITS IN POST-ACUTE SEQUELAE OF COVID-19 - ABSTRACT POST-ACUTE SEQUELAE OF COVID-19 (PASC), OR LONG COVID, IS AN EMERGING GLOBAL HEALTH CRISIS WITH AN URGENT NEED FOR OBJECTIVE ASSESSMENT TOOLS TO QUANTIFY NEUROCOGNITIVE… |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-26). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗